We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics

By LabMedica International staff writers
Posted on 26 Dec 2025

People with diabetes often need to measure their blood glucose multiple times a day, most commonly through finger-prick blood tests or implanted sensors. More...

These methods can be painful, inconvenient, and prone to skin irritation, leading many patients to test less frequently than recommended. Under-testing increases the risk of serious complications linked to poor glucose control. Researchers have now demonstrated a noninvasive way to measure blood glucose accurately using light, eliminating the need for needles or implanted sensors.

Researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) built a shoebox-sized device based on Raman spectroscopy, an optical technique that identifies chemical composition by analyzing how near-infrared light scatters within tissue. Instead of drawing blood or sampling interstitial fluid, the system shines light onto the skin and detects subtle glucose-specific signals mixed with background tissue signals. By redesigning the measurement approach, the device can assess glucose levels without breaking the skin or inserting any components into the body.

Earlier Raman-based systems required large, complex equipment because they analyzed the full Raman spectrum, which contains around 1,000 spectral bands. The MIT researchers simplified the process by identifying just three key bands needed for glucose detection—one glucose signal and two background references. This selective-band approach drastically reduced the size, cost, and complexity of the system, enabling glucose measurements with compact optical components while maintaining accuracy comparable to invasive monitoring technologies.

The device was evaluated in a clinical study at MIT’s Center for Clinical Translation Research. A healthy volunteer was monitored over four hours, with glucose readings taken every five minutes while the subject consumed two glucose drinks to induce changes in blood sugar. The findings, published in Analytical Chemistry, show that glucose measurements from the Raman-based device closely matched those from two commercially available continuous glucose monitors that rely on implanted sensors.

Although the initial prototype is not wearable, the researchers have already developed a smaller version, roughly the size of a smartphone, and are testing it in healthy and prediabetic volunteers. A larger clinical study involving people with diabetes is planned in collaboration with a local hospital. Future work focuses on shrinking the device further to a watch-sized format and ensuring accurate performance across different skin tones. If successful, the technology could enable comfortable, continuous glucose monitoring for a wide range of patients.

“For a long time, the finger stick has been the standard method for measuring blood sugar, but nobody wants to prick their finger every day, multiple times a day. Naturally, many diabetic patients are under-testing their blood glucose levels, which can cause serious complications,” said MIT research scientist Jeon Woong Kang, senior author of the study. “If we can make a noninvasive glucose monitor with high accuracy, then almost everyone with diabetes will benefit from this new technology.”

Related Links:
MIT


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.